Table 1.

BCR/ABL p190 del C transgenic founders

Founder no.Age at death (mo)RT-PCR*Cause of deathProgenyEst. transgene copy number
4208 28 Lymphoma Yes 
4212 24 − Unknown No 
4227 21 Unknown No 6-8 
4231 21 − Infection Yes 
4242 22 Unknown No 
4243 27.5 Carcinoid lung tumor1-153 Yes 
4237 27.5 Lung adenoma Yes 
4266 12 − Found dead Yes 
Founder no.Age at death (mo)RT-PCR*Cause of deathProgenyEst. transgene copy number
4208 28 Lymphoma Yes 
4212 24 − Unknown No 
4227 21 Unknown No 6-8 
4231 21 − Infection Yes 
4242 22 Unknown No 
4243 27.5 Carcinoid lung tumor1-153 Yes 
4237 27.5 Lung adenoma Yes 
4266 12 − Found dead Yes 
*

Expression was measured at 4 weeks of age on peripheral blood samples using RT-PCR and hybridization with a specific oligonucleotide probe as described previously for BCR/ABL p190 transgenics.22 

No significant pathologic findings were noted.

Animal had splenomegaly with a left shift in the myeloid series and decreased B- and T-cell numbers in bone marrow. However, no Bcr/Abl or endogenous c-Abl expression could be detected in the spleen.

F1-153

Bcr/Abl protein could not be detected in the tumor. The animal also had regenerative liver nodules/hyperplasia.

Close Modal

or Create an Account

Close Modal
Close Modal